Background of the drug treatment of glaucoma.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004234:Diuretics, Osmotic / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D010276:Parasympatholytics / Q000009:adverse effects; D010277:Parasympathomimetics / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D004234:Diuretics, Osmotic; D010276:Parasympatholytics; D010277:Parasympathomimetics